Core Points - The company has decided to cancel its supervisory board, transferring its responsibilities to the audit committee of the board of directors, in order to enhance corporate governance and comply with regulatory requirements [1][2] - The company's registered capital will be increased from RMB 190,952,305 to RMB 210,139,246 due to the conversion of convertible bonds, resulting in an increase in total shares from 190,952,305 to 210,139,246 [2][3] - Amendments to the company's articles of association will be made to reflect the cancellation of the supervisory board and the changes in registered capital [3][4] Company Structure Changes - The supervisory board will be abolished, and its functions will be assumed by the audit committee of the board of directors [1][2] - The current members of the supervisory board will no longer hold their positions following the cancellation [2] Capital Changes - The company issued 5,433,100 convertible bonds with a total value of RMB 54,331,000, which began conversion on March 1, 2021 [2] - The total number of shares will increase by 19,186,941 shares due to the conversion of the bonds [2] Articles of Association Amendments - The articles of association will be revised to reflect the cancellation of the supervisory board and the increase in registered capital [3][4] - Specific articles will be updated to maintain compliance with the latest laws and regulations [3][4]
塞力医疗: 关于取消监事会、变更公司注册资本并修订《公司章程》及修订和制定部分管理制度的公告